Answers are grounded in this paper and cite their sources.
Evaluates bee pollen's effects on metabolic syndrome indicators, suggesting its use as a functional ingredient.
Oxidative stress and chronic inflammation are associated with metabolic disorders such as obesity and diabetes. Based on bee pollen composition, it may serve to prevent or mitigate metabolic disorders or ameliorate their associated pathogenesis (counteracting reactive oxygen species (ROS), reducing the chronic inflammatory context, and inhibiting digestive enzymes such as α‐glucosidase and pancreatic lipase). Thus, the objective of this work was to determine the potential of four commercial bee pollens, from China (MT, EN, and CA) and Spain (MA), for their use as a functional ingredient and/or nutraceutical. The composition and in vitro bioactive properties (antioxidant, including intracellular ROS formation, anti‐inflammatory, and inhibition of digestive enzymes) were assessed. Total phenolic content, ABTS, and ORAC‐FL values were higher for MA (5.75–7.34 mg GAE/g, 61.03–91.81, and 80.28–137.67 μmol TE/g, respectively). Inhibition of intracellular ROS formation in Caco‐2 intestinal cells was higher for MA (300–1000 μg/mL) and CA (50–1000 μg/mL) under AAPH (1 mM)‐induced oxidation conditions (compared to the control DMEM with AAPH, p < 0.05). The anti‐inflammatory effect was higher for CA (300–800 μg/mL) under LPS‐induced nitric oxide production in RAW264.7 macrophages (compared to the control DMEM with LPS, p < 0.05). Bee pollen samples showed no significant differences in α‐glucosidase inhibition capacity (IC 50 = 6.95–7.51 mg/mL, p > 0.05), whereas pancreatic lipase inhibition was higher for MA and EN (IC 50 = 25.05 and 22.29 mg/mL, respectively, p > 0.05). In conclusion, commercial bee pollen samples present the potential to be used as a nutraceutical and/or functional ingredient by counteracting oxidative stress and chronic inflammation associated with metabolic disorders. Bioavailability studies should be conducted to confirm their potential.
No takes yet. Share an insight, caveat, or question.
Fernández‐Fernández et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: